Physician drug prescribing preferences and availability for ventilation of patients with COVID-19

Ian Coombes, Michael Dooley, Shane Townsend, Sinead Carmichael , Susan G. Poole, Nermin Karamujic, Brent Richards, Marc D. Ziegenfuss, Melissa Ankrvas, Hailie Uren, Jason Roberts, Anthony Holley

Research output: Contribution to journalArticleOtherpeer-review

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure. The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia. In the setting of severe acute respiratory failure, neuromuscular blockade is often required.
Original languageEnglish
Pages (from-to)271-274
Number of pages4
JournalCritical Care and Resuscitation
Volume22
Issue number3
Publication statusPublished - 1 Sep 2020

Cite this